19 Indberettede kliniske og laboratoriemæssige abnormaliteter, blandt voksne patienter, der er behandlet med CANCIDAS (i alt 989), var sædvanligvis milde og krævede sjældent seponering.
19 Reported clinical and laboratory abnormalities among all adult patients treated with CANCIDAS (total 989) were typically mild and rarely led to discontinuation.